Corbevax

HYDERABAD/NEW DELHI: Union health secretary Rajesh Bhushan said there will be no change in existing guidelines for homologous precaution dose administration of Covaxin and Covishield vaccine. The government has cleared Corbevaxas the…

HYDERABAD: In what is the first heterologous booster shot to be approved, Biological E’s Covid-19 vaccine Corbevaxis learnt to have received the government’s nod for use as a booster or precaution dose for those aged 18 and above that…

Biological E's Corbevax vaccine might soon get an approval by the health ministry to be used as a booster dose for people above 18 years, who are double vaccinated with either Covishield or Covaxin, reported PTI citing official sources…

Mumbai: Biological E (BE) said it has submitted Corbevax to WHO for emergency use listing (EUL) and "detailed review" of the application is underway. A top executive of the Hyderabad-based vaccine maker said a WHO inspection team audited…

NEW DELHI: The National Technical Advisory Group on Immunisation's Covid working group has reviewed the data of Biological E's Corbevax to allow it as booster for those aged 18 and above fully vaccinated with Covishield or Covaxin,…

New Delhi: The crucial meeting of the Covid working group to decide on the inclusion of India's first mRNA vaccine in the vaccination programme and review Biological E's Corbevax as a booster dose for those adults who have received both…

The Standing Technical Sub-Committee (STSC) of the NTAGI on Friday recommended the use of Bharat Biotech's Covaxin and Corbevax vaccines for Covid-19 for children aged between five and 12 years. Data of Biological E's Corbevax and Bharat…

The National Technical Advisory Group on Immunisation (NTAGI) is likely to review the data of Corbevax to consider allowing it to be administered to those fully vaccinated with Covishield or Covaxin, amid emergence of new sub lineage in…

NEW DELHI: Allowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin is likely to be considered by the NTAGI, which is scheduled to meet on Tuesday, sources said. The…

By Payal Banerjee New Delhi, Government advisory panel NTAGI will meet on Thursday to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses…